Literature DB >> 12879005

Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases.

Takahisa Takino1, Naohiko Koshikawa, Hisashi Miyamori, Motohiro Tanaka, Takuma Sasaki, Yasunori Okada, Motoharu Seiki, Hiroshi Sato.   

Abstract

A human placenta cDNA library was screened by the expression cloning method for gene products that interact with matrix metalloproteinases (MMPs), and we isolated a cDNA whose product formed a stable complex with pro-MMP-2 and pro-MMP-9. The cDNA encoded the metastasis suppressor gene KiSS-1. KiSS-1 protein was shown to form a complex with pro-MMP. KiSS-1 protein is known to be processed to peptide ligand of a G-protein-coupled receptor (hOT7T175) named metastin, and suppresses metastasis of tumors expressing the receptor. Active MMP-2, MMP-9, MT1-MMP, MT3-MMP and MT5-MMP cleaved the Gly118-Leu119 peptide bond of not only full-length KiSS-1 protein but also metastin decapeptide. Metastin decapeptide induced formation of focal adhesion and actin stress fibers in cells expressing the receptor, and digestion of metastin decapeptide by MMP abolished its ligand activity. Migration of HT1080 cells expressing hOT7T175 that harbor a high-level MMP activity was only slightly suppressed by either metastin decapeptide or MMP inhibitor BB-94 alone, but the combination of metastin decapeptide and BB-94 showed a synergistic effect in blocking cell migration. We propose that metastin could be used as an antimetastatic agent in combination with MMP inhibitor, or MMP-resistant forms of metastin could be developed and may also be efficacious.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879005     DOI: 10.1038/sj.onc.1206542

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Altered plasma matrix metalloproteinase-9/tissue inhibitor of matrix [corrected] metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer.

Authors:  I Kirman; S Jain; V Cekic; A Belizon; E Balik; P Sylla; T Arnell; K A Forde; R L Whelan
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

3.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Authors:  Ying-Chi Ip; Siu-Tim Cheung; Ka-Ling Leung; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

4.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E Votsi; D Roussos; I Katsikis; A Karkanaki; M Kita; D Panidis
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

5.  Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands.

Authors:  Shinya Oishi; Ryosuke Misu; Kenji Tomita; Shohei Setsuda; Ryo Masuda; Hiroaki Ohno; Yousuke Naniwa; Nahoko Ieda; Naoko Inoue; Satoshi Ohkura; Yoshihisa Uenoyama; Hiroko Tsukamura; Kei-Ichiro Maeda; Akira Hirasawa; Gozoh Tsujimoto; Nobutaka Fujii
Journal:  ACS Med Chem Lett       Date:  2010-10-25       Impact factor: 4.345

6.  MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.

Authors:  X Cheng; Y Yang; Z Fan; L Yu; H Bai; B Zhou; X Wu; H Xu; M Fang; A Shen; Q Chen; Y Xu
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

7.  EP24.15 as a Potential Regulator of Kisspeptin Within the Neuroendocrine Hypothalamus.

Authors:  Nicole C Woitowich; Keith D Philibert; Randy J Leitermann; Manida Wungjiranirun; Janice H Urban; Marc J Glucksman
Journal:  Endocrinology       Date:  2015-12-11       Impact factor: 4.736

8.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

9.  Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).

Authors:  Sunao Shoji; Xian Yang Tang; Haruhiro Sato; Yukio Usui; Toyoaki Uchida; Toshiro Terachi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

10.  KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.

Authors:  Sung-Gook Cho; Dali Li; Lewis J Stafford; Jian Luo; Melissa Rodriguez-Villanueva; Ying Wang; Mingyao Liu
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.